This inventor holds 2 USPTO granted patents. Top assignee: Fmc Corporation. Active years: 1997-1998.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1997-1998
Title: The Innovations of William J Reilly, Jr.
Introduction
William J Reilly, Jr. is a notable inventor based in New Hope, PA (US). He has made significant contributions to the field of pharmaceuticals, holding 2 patents that showcase his innovative spirit and dedication to improving drug formulations.
Latest Patents
Reilly's latest patents include advancements in pharmaceutical suspensions and chewable tablets. His patent on "MCC: alginate pharmaceutical suspensions" describes novel pharmaceutical suspensions that comprise a pharmaceutically active ingredient suspended in aqueous media. This formulation utilizes a suspending agent made from attrited microcrystalline cellulose that is coprocessed and partially surface coated with a calcium sodium alginate salt complex barrier dispersant. The patent exemplifies readily dispersible and hydratable dry formulations. Additionally, his patent for "Chewable pharmaceutical tablets" outlines formulations designed for the delivery of various pharmaceutical actives. These tablets utilize an aggregate of coprocessed microcrystalline cellulose and a galactomannan as excipients, which enhance the smell, taste, texture, and mouthfeel of the final product.
Career Highlights
William J Reilly, Jr. is associated with FMC Corporation, where he continues to innovate in the pharmaceutical sector. His work has significantly impacted the development of more effective and user-friendly pharmaceutical products.
Collaborations
Throughout his career, Reilly has collaborated with esteemed colleagues such as Sheila M Dell and John A Colliopoulos. These partnerships have fostered a creative environment that encourages the development of groundbreaking pharmaceutical solutions.
Conclusion
William J Reilly, Jr. exemplifies the spirit of innovation in the pharmaceutical industry. His contributions through patents and collaborations highlight his commitment to enhancing drug formulations for better patient experiences.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
